Ramsay Health Care (RHC) CMD 2026 summary
Event summary combining transcript, slides, and related documents.
CMD 2026 summary
21 Sep, 2026Strategic vision and future roadmap
Unveiled Connecting Care 2030, a strategic plan focused on profitable growth, medical excellence, integrated care, and digital and outpatient service expansion across Europe.
Five strategic pillars: active portfolio and contract management, integrated and accessible healthcare, digital transformation, cost initiatives, and new revenue streams.
Emphasis on leveraging medical excellence, people, data/AI, brand, customer centricity, sustainability, and IT infrastructure as core capabilities.
Ongoing network rationalisation and activity transfer to optimise capacity and align with demand.
Continued diversification outside France, with outpatient and digital patient growth driving expansion.
Financial performance and guidance
Achieved 3.9% CAGR revenue growth over two years, reaching €5.4 billion in FY 2026, with EBITDA margin at 11.9%.
Performance plan initiatives delivered €80 million additional EBITDA in FY 2026, with further upside identified.
Guidance for 2027–2029: 3% average annual revenue growth, stable then gradually improving EBITDA margin, gross CapEx at 4% of revenue, and deleveraging to below 4x net debt/EBITDA.
Net capex averaged 2.7% of revenue, prioritising high-impact investments in imaging, digital, and minimally invasive surgery.
Capital allocation remains disciplined, with no major M&A planned and a stable real estate policy.
Market positioning and operational highlights
Leading pan-European healthcare provider with strong positions in France, Sweden, Denmark, and Norway, serving 13 million patients annually.
High barriers to entry in core markets due to regulation, authorizations, and medical expertise.
Integrated care model enables internal referrals and continuity across primary, specialty, mental health, and at-home care.
Digital transformation advanced through AI tools, digital admissions, and ambient scribe technology, especially in the Nordics.
Medical excellence recognized by external accreditations, high NPS scores, and superior clinical outcomes in key specialties.
Latest events from Ramsay Health Care
- Underlying NPAT up 23% YoY, EBIT and margin growth, leverage down, and demerger progressing.RHC
H2 2026 - Underlying NPAT up 8.1% and EBIT 7.3%, driven by Australian growth and portfolio actions.RHC
H1 2026 - Ramsay Santé shares will be distributed to shareholders, providing direct exposure and strategic clarity.RHC
Status update - Profit up, dividend maintained, transformation and leadership renewal amid industry headwinds.RHC
AGM 2025 - Underlying profit rose, but net profit plunged on UK impairment; transformation ongoing.RHC
H2 2025 - Leadership transition, margin recovery, and transformation drive future growth and resilience.RHC
AGM 2024 - Transformation and network expansion drive margin uplift, efficiency, and sustainable growth.RHC
Investor Update - Underlying profit up 24.5%, leverage at 2x, with margin pressure expected in FY25.RHC
H2 2024 - Underlying profit up 10.7% as Australia and UK growth offset Elysium and Europe headwinds.RHC
H1 2025